Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$27.52 - $37.99 $1,816 - $2,507
-66 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$30.71 - $45.71 $2,026 - $3,016
66 New
66 $2,000
Q4 2021

Feb 14, 2022

SELL
$37.06 - $47.11 $6,151 - $7,820
-166 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$40.26 - $57.37 $6,683 - $9,523
166 New
166 $7,000
Q1 2021

May 17, 2021

SELL
$70.65 - $96.76 $13,352 - $18,287
-189 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$58.41 - $89.06 $11,039 - $16,832
189 New
189 $16,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $333M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.